Natalie Dean – MIDAS

Natalie Dean

Assistant Professor

Education

Affiliations

Department of Biostatistics, College of Public Health and Health Professions, University of Florida
Center for Inference & Dynamics of Infectious Disease, Fred Hutchinson Cancer Research Center

Projects

DESIGN AND ANALYSIS OF VACCINE TRIALS FOR EMERGING INFECTIOUS DISEASE THREATS

National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Ira Longini, Natalie Dean
2018 – 2023

METHODS FOR EVALUATING VACCINE EFFICACY

National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Ira Longini, Natalie Dean, Yang Yang, M Halloran
2015 – 2020

CENTER FOR STATISTICS AND QUANTITATIVE INFECTIOUS DISEASES

National Institutes of Health, National Institute of General Medical Sciences
People: Natalie Dean, Katia Koelle, Molly Gallagher, John Drake, Ana Pastore y Piontti, Laura Matrajt, Yang Yang, M Halloran, Eben Kenah, Diana Rojas Alvarez, Pejman Rohani, Aaron King
2014 – 2020

Papers

Aleta A, Martin-Corral D, Pastore Y Piontti A, Ajelli M, Litvinova M, Chinazzi M, Dean NE, Halloran ME, Longini IM, Merler S, Pentland A, Vespignani A, Moro E, Moreno Y. (2020). Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic. medRxiv : the preprint server for health sciences

Jing QL, Liu MJ, Zhang ZB, Fang LQ, Yuan J, Zhang AR, Dean NE, Luo L, Ma MM, Longini I, Kenah E, Lu Y, Ma Y, Jalali N, Yang ZC, Yang Y. (2020). Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study. The Lancet. Infectious diseases

Dean NE, Halloran ME, Longini IM Jr.. (2020). Temporal Confounding in the Test Negative Design. American journal of epidemiology

Kimmel SE, Califf RM, Dean NE, Goodman SN, Ogburn EL. (2020). COVID-19 Clinical Trials: A Teachable Moment for Improving Our Research Infrastructure and Relevance. Annals of internal medicine

Ogburn EL, Bierer BE, Brookmeyer R, Choirat C, Dean NE, De Gruttola V, Ellenberg SS, Halloran ME, Hanley DF Jr., Lee JK, Wang R, Scharfstein DO. (2020). Aggregating data from COVID-19 trials. Science (New York, N.Y.), 368(6496)

Dean NE, Gsell PS, Brookmeyer R, Crawford FW, Donnelly CA, Ellenberg SS, Fleming TR, Halloran ME, Horby P, Jaki T, Krause PR, Longini IM, Mulangu S, Muyembe-Tamfum JJ, Nason MC, Smith PG, Wang R, Henao-Restrepo AM, De Gruttola V. (2020). Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks. The New England journal of medicine, 382(14)

Yang Yang, Lu Qingbin, Liu Mingjin, Wang Yixing, Zhang Anran, Jalali Neda, Dean Natalie, Longini Ira, Halloran M. Elizabeth, Xu Bo, Zhang Xiaoai, Wang Liping, Liu Wei, Fang Liqun. (2020). Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. Cold Spring Harbor Laboratory Press

Dean NE. (2019). RE: "MEASUREMENT OF VACCINE DIRECT EFFECTS UNDER THE TEST-NEGATIVE DESIGN". American journal of epidemiology, 188(4)

Ding AA, Wu SS, Dean NE, Zahigian RS. (2019). Two-stage adaptive enrichment design for testing an active factor. Journal of biopharmaceutical statistics, 30(1)

Bellan SE, Eggo RM, Gsell PS, Kucharski AJ, Dean NE, Donohue R, Zook M, Edmunds WJ, Odhiambo F, Longini IM Jr., Brisson M, Mahon BE, Henao-Restrepo AM. (2019). An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool. Vaccine, 37(31)

Dean NE, Gsell PS, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, Jasseh M, Nason M, Riveros X, Watson CH, Henao-Restrepo AM, Longini IM. (2019). Design of vaccine efficacy trials during public health emergencies. Science translational medicine, 11(499)

Ma MJ, Zhao T, Chen SH, Xia X, Yang XX, Wang GL, Fang LQ, Ma GY, Wu MN, Qian YH, Dean NE, Yang Y, Lu B, Cao WC. (2018). Avian Influenza A Virus Infection among Workers at Live Poultry Markets, China, 2013-2016. Emerging infectious diseases, 24(7)

Sun K, Zhang Q, Pastore-Piontti A, Chinazzi M, Mistry D, Dean NE, Rojas DP, Merler S, Poletti P, Rossi L, Halloran ME, Longini IM Jr., Vespignani A. (2018). Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015-2016 ZIKV epidemic. BMC medicine, 16(1)

Dean NE, Halloran ME, Longini IM. (2018). Design of vaccine trials during outbreaks with and without a delayed vaccination comparator. The annals of applied statistics, 12(1)

Zhang Q, Sun K, Chinazzi M, Pastore Y Piontti A, Dean NE, Rojas DP, Merler S, Mistry D, Poletti P, Rossi L, Bray M, Halloran ME, Longini IM Jr., Vespignani A. (2017). Spread of Zika virus in the Americas. Proceedings of the National Academy of Sciences of the United States of America, 114(22)

Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Kondé MK, Kéïta S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Røttingen JA, Kieny MP. (2017). Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet, 389(10068)

Rojas DP, Dean NE, Yang Y, Kenah E, Quintero J, Tomasi S, Ramirez EL, Kelly Y, Castro C, Carrasquilla G, Halloran ME, Longini IM. (2016). The epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 21(28)

Ajelli M, Merler S, Fumanelli L, Pastore Y Piontti A, Dean NE, Longini IM Jr., Halloran ME, Vespignani A. (2016). Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis. BMC medicine, 14(1)

Dean NE, Halloran ME, Yang Y, Longini IM. (2016). Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62(10)

Fang LQ, Yang Y, Jiang JF, Yao HW, Kargbo D, Li XL, Jiang BG, Kargbo B, Tong YG, Wang YW, Liu K, Kamara A, Dafae F, Kanu A, Jiang RR, Sun Y, Sun RX, Chen WJ, Ma MJ, Dean NE, Thomas H, Longini IM Jr., Halloran ME, Cao WC. (2016). Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone. Proceedings of the National Academy of Sciences of the United States of America, 113(16)

Merler S, Ajelli M, Fumanelli L, Parlamento S, Pastore Y Piontti A, Dean NE, Putoto G, Carraro D, Longini IM Jr., Halloran ME, Vespignani A. (2016). Containing Ebola at the Source with Ring Vaccination. PLoS neglected tropical diseases, 10(11)

Longini IM, Egger M, Dean NE, Edmunds WJ, Henao-Restrepo AM, . (2015). Ebola vaccination - Authors' reply. Lancet, 386(10012)